US Eylea Biosimilar Approvals Set Up Competition On Aflibercept

Both Biocon And Biogen Receive Interchangeability Designations For Ophthalmic Treatment

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.